The stem cell treatment has been tested by key scientific organizations throughout the world, including those in China and the United States. Some people have experienced positive outcomes. The benefit of stem cells is that they have potent anti-inflammatory and immunomodulatory characteristics, which can aid in the strengthening of our immune systems.
Stem cells are known as the primary database of the human body, which can answer thousands of questions raised by experts in connection with a particular health state. It has genetic details that can help one to face tremendous health issues also and get rid of them with the right treatment of the same.
How Stem Cell Treatment Could Have Been The Key To Battling Covid-19?
This is particularly significant in the case of covid-19 since they may be able to decrease inflammation in the lungs, which are the most severely impacted. The treatment includes injecting mesenchymal stem cells (MSC) from a human placenta into a covid-19 patient through intravenous injection to enhance the body’s immunological response to the infection. This process yet failed to meet the expectations.
While stem cell therapy, which uses stem cells to promote regeneration, repair, or healing, can be used to treat a variety of illnesses and disorders, there are presently not clinically studied or government-approved cell treatments for the treatment or prevention of COVID-19 or its long-term consequences.
According to lead author Laertis Ikonomou, Ph.D., associate professor of oral biology at the University at Buffalo School of Dental Medicine, “this hasn’t stopped the emergence of clinics offering unproven and unsafe “stem cell” therapies that promise to prevent COVID-19 by strengthening the immune system or improving overall health.
“Efforts to create therapeutic treatments quickly should never come at the price of the ethical and scientific norms that underpin responsible clinical research and innovation,” Ikonomou adds.
Unproven stem cell treatments have been linked to physical impairment in individuals, including blindness and death. Patients are also harmed financially, according to Ikonomou, because the goods range in price from a few thousand to tens of thousands of dollars, and individuals are frequently pushed to get the costly treatments every few months. According to Turner, patients who feel they are immune to COVID-19 may refuse immunization, stop wearing masks, discontinue physical distance, or otherwise eschew actions that promote personal safety and public health. They may also be less willing to participate in properly designed clinical studies run by businesses.
Many of the research on potential stem cell-based COVID-19 therapies are still in the early stages of development, and bigger sample numbers are needed, according to Munsie. The results of early research, on the other hand, are regularly inflated in press releases, social media, and uncritical news media stories.
According to Turner, clinics offering alleged stem cell therapies directly to consumers often exploit the anxieties of vulnerable patients by unethically promoting the unproven advantages of stem cell treatments to strengthen the immune system, repair lung tissue, and inhibit COVID-19 transmission.
Unproven stem cell treatments have been linked to physical damage in individuals, including blindness and death. Patients are also harmed financially, according to Ikonomou, because the goods range in price from a few thousand to tens of thousands of dollars, and individuals are frequently pushed to get the costly treatments every few months.
Despite the fact that the US Food and Drug Administration and the Federal Trade Commission have given warnings to a number of violating clinics, many continue to make misleading claims.
They also recommend that scientific and professional groups contact regulatory bodies to ensure that rules and regulations are enforced more strictly. According to the authors, science communicators and media may counteract misinformation by avoiding exaggerated coverage of research findings and communicating study limitations.
